# OnCo record vor-biopharma (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/vor-biopharma/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "vor-biopharma" ;
  schema:name "Vor Biopharma"@en ;
  schema:alternateName "Vor Biopharma Inc."@en, "VOR BIOPHARMA INC."@en ;
  schema:description "Vor is a Cambridge cell-therapy company that edits the CD33 gene out of donor stem cells so that leukaemia patients can receive CD33-targeting therapy after transplant without harming their new marrow."@en ;
  schema:url <https://onco.cc/companies/vor-biopharma/>, <https://www.vorbio.com> ;
  schema:dateModified "2026-09-11"^^xsd:date ;
  schema:citation <https://www.vorbio.com>, <https://clinicaltrials.gov/search?lead=Vor%20Biopharma%20Inc.>, <https://www.wikidata.org/wiki/Q140609057> ;
  onco:tag "ctgov-sponsor" ;
  schema:addressCountry "US" ;
  onco:cancers <https://onco.cc/cancers/aml/> ;
  onco:technologies <https://onco.cc/technologies/allogeneic-hsct/>, <https://onco.cc/technologies/car-t/> ;
  onco:targets <https://onco.cc/targets/cd33/> ;
  onco:terms <https://onco.cc/terms/pivotal-trial/>, <https://onco.cc/terms/clinical-trial/> .